🇦🇺 Australia Country × Condition
chronic lymphocytic leukemia Clinical Trials in Australia
Active clinical trials for chronic lymphocytic leukemia with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT06812715 Phase 2
Recruiting
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
Enrollment
40 pts
Country
🇦🇺 Australia
Peter MacCallum Cancer Centre, Aust...
View Trial → NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Enrollment
645 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT07277231 Phase 3
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Enrollment
500 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → Frequently Asked Questions
How many chronic lymphocytic leukemia clinical trials are active in Australia?
There are currently 3 active clinical trials for chronic lymphocytic leukemia with sites in Australia, of which 3 are actively recruiting patients.
How can I join a chronic lymphocytic leukemia clinical trial in Australia?
To join a chronic lymphocytic leukemia clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are chronic lymphocytic leukemia trials in Australia?
Active chronic lymphocytic leukemia trials in Australia span Phase 2, Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology